Hipertensiunea portală intrahepatică de origine virală la copil opţiuni terapeutice

Selectează perioada

De la

Pîna la

2022

BAZINET, M., Replicor, Montreal, QC, Canada, ANDERSON, M., Abbott Diagnostics, Abbott Park, IL, Statele Unite ale Americii, PÂNTEA, V., dr.hab, PLĂCINTĂ, G., dr., MOSCALU, I., dr., CEBOTARESCU, V., dr., COJUHARI, L., dr., JIMBEI, P., IAROVOI, L., dr., SMESHNOI, V., dr., MUSTEAŢĂ, T., JUCOV, A., dr., DITTMER, U., Universitatea din Duisburg-Essen, Germania, GERSCH, J., Abbott Diagnostics, Abbott Park, IL, Statele Unite ale Americii, HOLZMAYER, V., Abbott Diagnostics, Abbott Park, IL, Statele Unite ale Americii, KUHNS, M., Abbott Diagnostics, Abbott Park, IL, Statele Unite ale Americii, CLOHERTY, G., Abbott Diagnostics, Abbott Park, IL, Statele Unite ale Americii, VAILLANT, A., Replicor, Montreal, QC, Canada HBsAg isoform dynamics during NAP-based therapy of HBeAg-negative chronic HBV and HBV/HDV infection. Hepatology Communications. 2022, nr. , 1880-1870. ISSN 2471-254X.

YUEN, M., Universitatea Chineză din Hong Kong, China, BERLIBA, E., dr., SUKEEPAISARNJAROEN, W., Khon Kaen University, Tailanda, AHN, S., Universitatea Yonsei, Seul, Coreea de Sud, TANWANDEE, T., Universitatea Mahidol, Bangkok, Tailanda, LIM, Y., Centrul Medical Asan, Seul, Coreea de Sud, KIM, Y., Seoul National University, Coreea de Sud, POOVORAWAN, K., Universitatea Mahidol, Bangkok, Tailanda, TANGKIJVANICH, P., Chulalongkorn University, Tailanda, SCHWABE, C., Studii clinice Auckland, Auckland, Noua Zeelandă, ELEY, T., Arbutus Biopharma, Warminster, Statele Unite ale Americii, BROWN, J., Arbutus Biopharma, Warminster, Statele Unite ale Americii, NOI, A., GANE, E., Universitatea din Auckland, Noua Zeelandă Safety, pharmacokinetics, and antiviral activity of the capsid inhibitor AB-506 from Phase 1 studies in healthy subjects and those with hepatitis B. Hepatology Communications. 2022, nr. , 3472-3457. ISSN 2471-254X.

2021

BAZINET, M., Replicor, Montreal, QC, Canada, PÂNTEA, V., dr.hab, CEBOTARESCU, V., dr., COJUHARI, L., dr., JIMBEI, P., ANDERSON, M., Abbott Diagnostics, Abbott Park, IL, Statele Unite ale Americii, GERSCH, J., Abbott Diagnostics, Abbott Park, IL, Statele Unite ale Americii, HOLZMAYER, V., Abbott Diagnostics, Abbott Park, IL, Statele Unite ale Americii, ELSNER, C., Universitatea din Duisburg-Essen, Germania, KRAWCZYK, A., Universitatea din Duisburg-Essen, Germania, KUHNS, M., Abbott Diagnostics, Abbott Park, IL, Statele Unite ale Americii, CLOHERTY, G., Abbott Diagnostics, Abbott Park, IL, Statele Unite ale Americii, DITTMER, U., Universitatea din Duisburg-Essen, Germania, VAILLANT, A., Replicor, Montreal, QC, Canada Persistent Control of Hepatitis B Virus and Hepatitis Delta Virus Infection Following REP 2139-Ca and Pegylated Interferon Therapy in Chronic Hepatitis B Virus/Hepatitis Delta Virus Coinfection. Hepatology Communications. 2021, nr. , 202-189. ISSN 2471-254X.

BAZINET, M., Replicor, Montreal, QC, Canada, ANDERSON, M., Abbott Diagnostics, Abbott Park, IL, Statele Unite ale Americii, PÂNTEA, V., dr.hab, PLĂCINTĂ, G., dr., MOSCALU, I., dr., CEBOTARESCU, V., dr., COJUHARI, L., dr., JIMBEI, P., IAROVOI, L., dr., SMESHNOI, V., dr., MUSTEAŢĂ, T., JUCOV, A., dr., DITTMER, U., Universitatea din Duisburg-Essen, Germania, GERSCH, J., Abbott Diagnostics, Abbott Park, IL, Statele Unite ale Americii, HOLZMAYER, V., Abbott Diagnostics, Abbott Park, IL, Statele Unite ale Americii, KUHNS, M., Abbott Diagnostics, Abbott Park, IL, Statele Unite ale Americii, CLOHERTY, G., Abbott Diagnostics, Abbott Park, IL, Statele Unite ale Americii, VAILLANT, A., Replicor, Montreal, QC, Canada Analysis of HBsAg Immunocomplexes and cccDNA Activity During and Persisting After NAP-Based Therapy. Hepatology Communications. 2021, nr. , 1887-1873. ISSN 2471-254X.

1-4 of 4